Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc.

2.92
EUR
0.00
(0.00%)
-0.72EPS
645.35MMarket Cap
Nov 05Next Earn

Latest Stock Split

Sep 30, 2019

1:4

For every 4 shares held, investors received 1.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Sep 30, 2019
    Before—
    Split ratio1:4
    After—
    Reverse
  2. Aug 12, 2015
    Before—
    Split ratio1:5
    After—
    Reverse

About Relmada Therapeutics, Inc. stock splits

Relmada Therapeutics, Inc. (GETTEX:4E2) operates in the Pharmaceuticals: major industry.

Relmada Therapeutics, Inc. company overview

When did Relmada Therapeutics, Inc. stock split?

Relmada Therapeutics, Inc.'s most recent stock split was on September 30, 2019. It was a 1-for-4 reverse split, so shareholders received 1 share for every 4 they held.

What is Relmada Therapeutics, Inc.'s stock split history?

Relmada Therapeutics, Inc. (GETTEX:4E2) has split its stock 2 times: a 1-for-5 reverse split on August 12, 2015 and a 1-for-4 reverse split on September 30, 2019.

How many times has Relmada Therapeutics, Inc. stock split?

Relmada Therapeutics, Inc. has split its stock 2 times. This history records 2 reverse splits between August 12, 2015 and September 30, 2019.

What is a reverse stock split?

A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Relmada Therapeutics, Inc.'s 1-for-4 reverse split on September 30, 2019, every 4 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.

Will Relmada Therapeutics, Inc. split its stock again?

Relmada Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on September 30, 2019, 7 years ago. Companies announce splits in advance, and any new GETTEX:4E2 split will appear on this page.